<DOC>
	<DOCNO>NCT00673465</DOCNO>
	<brief_summary>The purpose study evaluate effect SCH 497079 metabolic parameter determine influence race/ethnic origin therapeutic response .</brief_summary>
	<brief_title>Effect SCH 497079 Metabolic Parameters Influence Race/Ethnic Origin Therapeutic Response ( Study P05338 ) ( COMPLETED )</brief_title>
	<detailed_description>This study include two part , part include three consecutive 28-day treatment period . Part 1 ( conduct United States ) : participant receive follow treatment 28 day three treatment period order determine random code : SCH 497079 , match placebo , metformin . Part 2 ( conduct India ) : part study conduct completion Part 1 analysis indicate clinically significant decrease blood glucose participant type 2 diabetes mellitus ( T2DM ) compare placebo . The procedure conduct Part 1 conduct Part 2 .</detailed_description>
	<mesh_term>Diabetes Mellitus</mesh_term>
	<mesh_term>Diabetes Mellitus , Type 2</mesh_term>
	<mesh_term>Metformin</mesh_term>
	<criteria>&gt; =18 year age 65 year age , either sex , body mass index ( BMI ) 27 35 , inclusive ( USA participant ) Clinical laboratory test ( complete blood count , blood chemistry , urinalysis ) within normal limit ( exclude glucose change usually associate diabetes eg , dyslipidemia ) Type 2 diabetes mellitus Female participant premenopausal surgically sterilize . Participants pregnant , intend become pregnant ( within 3 month end study ) , breastfeed . Participants receive insulin therapy within 6 month , prior Day 1/Period 1 require thiazide diuretic , betablockers cyclic hormone therapy .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>65 Years</maximum_age>
	<verification_date>December 2016</verification_date>
</DOC>